On June 10, 2026, Danaher Corporation completed its acquisition of Masimo Corporation, making Masimo a wholly owned subsidiary of Danaher. Under the merger agreement, outstanding Masimo common stock was cancelled and converted into the right to receive $180.00 per share in cash. As part of the transaction, Masimo's common stock was delisted from the Nasdaq Stock Market. Masimo Corporation operates in the medical technology industry, providing non-invasive monitoring solutions.